The record
Written from the 1 report below. Nothing here is unsourced.
- India's clinical research industry is calling for a 'reverse brain drain' to help move the pharmaceutical sector from generics to innovative medicines.
- China attracted top scientific talent back home through its 'Thousand talents programme' and built an innovation ecosystem over 15-plus years.
- Indian diaspora scientists in global biopharma and international regulators could be brought back to meet India's need for highly skilled manpower.
- The Centre has announced ₹10,000 crore BioPharma Shakti funding and the PM Research Chair scheme to attract researchers from abroad.
- The industry says India also needs early-stage translational labs and faster regulatory approvals, or companies may choose Europe or Australia instead.
What to watch next
- Details of how the reverse brain drain of diaspora scientists will be implemented
- Rollout of early-stage translational labs in academic institutions and hospitals
- Changes in regulatory bandwidth and approval times for new therapies and biologicals
Who said what1
Only words found exactly in the article are shown, attributed and linked to the line they came from.
Anirban Roychowdhury
Honorary General Secretary of the Indian Society
1 quote · 1 outlet
“The Chinese government through its “Thousand talents programme” attracted top scientific talent back to the country”
In the article
…ecosystem and are today able to have “an inside-out product ...from China to the world,” Anirban Roychowdhury, Honorary General Secretary with the Indian Society for Clinical Research (ISCR) told businessline. The Chinese government through its “Thousand talents programme” attracted top scientific talent back to the country , said Roychowdhury, adding that several Indian diaspora who work in the international biopharmaceutical industry as scientists or are part of international regulatory framework as reviewers can be brought back to India…
Coverage1
All filed from India
Named India · China · Anirban Roychowdhury · Government of India · Indian Society for Clinical Research · Prime Minister Research Chair
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.
